Cite
Doi T, Yamamoto N, Naito Y, et al. Merestinib monotherapy or in combination for japanese patients with advanced and/or metastatic cancer: A phase 1 study. Cancer Med. 2021;10(19):6579-6589doi: 10.1002/cam4.4110.
Doi, T., Yamamoto, N., Naito, Y., Kuboki, Y., Koyama, T., Piao, Y., Tsujimoto, N., Asou, H., Inoue, K., & Kondo, S. (2021). Merestinib monotherapy or in combination for japanese patients with advanced and/or metastatic cancer: A phase 1 study. Cancer medicine, 10(19), 6579-6589. https://doi.org/10.1002/cam4.4110
Doi, Toshihiko, et al. "Merestinib monotherapy or in combination for japanese patients with advanced and/or metastatic cancer: A phase 1 study." Cancer medicine vol. 10,19 (2021): 6579-6589. doi: https://doi.org/10.1002/cam4.4110
Doi T, Yamamoto N, Naito Y, Kuboki Y, Koyama T, Piao Y, Tsujimoto N, Asou H, Inoue K, Kondo S. Merestinib monotherapy or in combination for japanese patients with advanced and/or metastatic cancer: A phase 1 study. Cancer Med. 2021 Oct;10(19):6579-6589. doi: 10.1002/cam4.4110. Epub 2021 Sep 09. PMID: 34499416; PMCID: PMC8495281.
Copy
Download .nbib